Transcript Slide 1
Janice Klunder and Sian Griffiths Legal Department, Millennium Pharmaceuticals, Inc.
SLA Pharmaceutical & Health Technology Division Spring Meeting Boston March 19th, 2007 © 2006 Millennium Pharmaceuticals Inc.
A Beautiful Friendship
The information professional and the patent attorney/agent
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 2
Patent and Drug Development Timelines FDA Approval Hatch-Waxman Extension US and International Applications Filed Patent Grant Patent Expiration Years 0 1 6 Development and FDA Review 11 US Provisional Application Filed 21 25
Maximum of 5 years extended term Maximum of 14 years of total patent term after NDA approval
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 3 initials/name of pres
What is a Patent?
• A grant of a property right – Property boundaries determined by the
claims
of the patent • Right to States
exclude
others from making, using, offering for sale, or selling the invention in the United States or “importing” the invention to the United
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 4 initials/name of pres
Patent Rights - Exclusionary Right
• A patent does
NOT
furnish the owner with the right to practice the claimed invention Company B
©2006 Millennium Pharmaceuticals, Inc.
• Company B can exclude Company A from practicing the claimed invention
BUT
, if Company A has a dominating patent • Company A can prevent Company B from practicing the broader claims, including Company B’s own invention initials/name of pres 4/24/2020 5
Requirements for Patentability
• New (novel) • Nonobvious • Useful • Adequate Disclosure – Written description – Enablement – Best Mode
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 6
Novelty- 35 U.S.C. § 102
• The invention must be new, and cannot be patented if: –
§102(a) - Before the applicant’s invention:
• The invention was published (by another) anywhere in the world;
or
• The invention was known or used by others in this country –
§102(b) - More than one year before applicant’s filing date:
• The invention was published by
anyone
anywhere in the world (1 year grace period for applicant’s publications);
or
• The invention was in public use or on sale in this country – e.g., manufacturing agreements for clinical trial materials
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 7 initials/name of pres
Novelty- 35 U.S.C. § 102-Genus-Species Relationships
Example 1: Species anticipates a claim to a genus Prior art
Claim is invalid:
Prior art species anticipates the claimed genus Novel compounds Hypothetical Patent Claim: All compounds characterized by having
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 8
Novelty- 35 U.S.C. § 102-Genus-Species Relationships
Example 2: Genus does not anticipate a claim to
an overlapping genus
Prior art patent claim
New claim is valid
: Prior art genus does not anticipate the claimed genus Prior art
Prior art patent does not disclose any specific compounds in the intersecting area
Novel compounds
©2006 Millennium Pharmaceuticals, Inc.
New patent claim initials/name of pres 4/24/2020 9
Obviousness- 35 U.S.C. § 103
• An invention cannot be patented if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious
at the time the invention was made
ordinary skill in the art to which said subject matter pertains to a person having – must be some suggestion or motivation to modify reference or to combine reference teachings – – must be a reasonable expectation of success; AND prior art reference(s) must teach or suggest all claim limitations
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 10
Novelty- 35 U.S.C. § 102-Genus-Species Relationships
Example 2: Genus does not anticipate a claim to
an overlapping genus
Prior art patent claim
New claim is invalid
: Claimed genus is obvious in view of the prior art patent Prior art
Prior art patent suggests making the combination
Novel compound
©2006 Millennium Pharmaceuticals, Inc.
New patent claim initials/name of pres 4/24/2020 11
Triggers for Conducting a Search
Discovery and Development
• • Early stage landscape analysis – Overview of patentability and FTO issues – Competitor assessment • Patent drafting – Patentability analysis Development decision points – Freedom-to-operate analysis – Competitor assessment
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 12
Triggers for Conducting a Search
Business Development
• Identification of business opportunities – Competitive intelligence • Due diligence – Patentability – Freedom-to-operate
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 13
Patent Information Professional
Who are they?
• • • • Information professional/analyst supporting Intellectual Property/Legal group Specialized in patent information Technology driven - chemical structure, biological sequence, medical devices May require different tools and different knowledge 4/24/2020 14
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres
Patent Information Professional
Key skills required
• General information skills – Business and company data, literature searching techniques etc.
• Knowledge of patent databases – Full-text or indexed – Dates and countries of coverage
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 15
Patent Information Professional
Key skills required cont.
• Specialized searching techniques and databases for different types of technology – Chemical structure or biological sequence • Data and Reporting – Use of tools for generation of reports – Access to full-text of patent documents
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 16
Patent Information Professional
Key skills required cont.
• Understanding of patent law basics – Tailor searches appropriately – Provide “value-added” analysis • Patent data analysis – Manual – Using specialized software
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 17
Examples
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 18
Example 1
Early Stage Landscape Analysis
• Types of searches typically employed – Sequence searches on drug target – Structure searches on high-throughput screening hit families – Keyword based patent and literature searches – Competitor profiles
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 19
Example 1
Early Stage Landscape Analysis
• Benefits to project team – May assist in the development of path forward for project team – Only one factor at early stage of project – Project should be science-driven unless significant obstacles are uncovered – Provide ongoing updates as project progresses
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres 4/24/2020 20
Example 2
Patent Drafting – Patentability Analysis
• No obligation to conduct a search but a thorough search is essential to identify relevant prior art and to avoid novelty and obviousness issues • More focused searches – Patent literature – Scientific literature – Commercial compounds
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 21 initials/name of pres
Example 2
Patent Drafting – Patentability Analysis
• Be aware of publication date vs date available in database • May monitor searches and update during patent application process • May do additional searches during patent prosecution in order to assist attorney in overcoming examiner’s rejections 4/24/2020 22
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres
Example 3
Development Decision Points
• Freedom-to-operate search and analyses – Searches on lead compound • Substructure, Markush, multiple sources – Searches on synthetic process route – Extensive keyword based patent searches across multiple databases – Often significant analyses of search results by attorneys required, information analyst assists
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 23 initials/name of pres
Example 3
Development Decision Points
• Freedom-to-operate search considerations – What is the question being asked – Breadth and scope will depend on type of decision point – Approach from several different angles – May lead to large results sets initial reviews – consider displays for result sets that may expedite
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 24 initials/name of pres
Example 3
Development Decision Points
• Competitor Assessment – Can be more commercial focused depending on decision point – Provide supplementary patent information as needed – May include analysis of key competitor(s) patent landscape 4/24/2020 25
©2006 Millennium Pharmaceuticals, Inc.
initials/name of pres
Tips and Tricks
Successful patent searching
• • • • • • Make the search process iterative Get input into strategies from other non-patent analysts and clients Have client sit with you when running searches Explain clearly the limitations and potential caveats of sources and searches Talk to clients about the best way for them to view/utilize your results Keep up-to-date with key changes in patent information eg. IPC8, database coverage
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 26 initials/name of pres
Tips and Tricks
Keys to successful relationships with clients
• • • Mutually trusting relationship between patent attorney/agent and information professional is critical If information professional does not report into Legal, work hard to establish matrix team One information professional for several attorneys/agents – try to keep up with priorities to effectively manage everyone’s filing dates and deadlines
©2006 Millennium Pharmaceuticals, Inc.
4/24/2020 27 initials/name of pres
Breakthrough science. Breakthrough medicine.
®